Anthera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 18   

Articles published

ANTH 0.561 -0.015 (-2.69%)
price chart
Anthera Pharmaceuticals Announces Personnel Changes
National Videos. By Anthera Pharmaceuticals, Inc. HAYWARD, Calif., June 12, 2013 - /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced the appointment of May Liu as its Senior Vice President, Finance and Administration.
Related articles »  
ANTHERA PHARMACEUTICALS INC : Anthera Pharmaceuticals to Present at ...
HAYWARD, Calif., May 31, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, announced today that Paul F. Truex, ...
Related articles »  
Cytori Therapeutics Inc (NASDAQ:CYTX) up by 2.80%, Anthera Pharmaceuticals ...
Cytori Therapeutics Inc (NASDAQ:CYTX): In Tuesday's trading session, Cytori Therapeutics Inc (NASDAQ:CYTX) jumped 2.80%.
USA Technologies Inc (NASDAQ:USAT) trades flat, Anthera Pharmaceuticals Inc ...
New York, NY - (NISMAGAZINE) - 5/28/2013- USA Technologies, Inc (NASDAQ:USAT) Tuesday's trading session saw USA Technologies, Inc (NASDAQ:USAT) up by 1.15%. It opened at a price of $1.78 which reached an intraday high of $1.80 and currently ...
Exide Technologies (NASDAQ:XIDE) loses 44.49% of its market cap, Anthera ...
Anthera Pharmaceuticals Inc (NASDAQ:ANTH) is now down 0.91% to currently hover around $0.601. The stock has seen a volume of 0.344 million in the current trading session so far, the average volume in the stock over a period of 90 days is 778.46K.
Related articles »  
Icahn ally added to Forest board
Anthera Pharmaceuticals ($ANTH) has appointed May Liu as its senior vice president of finance and administration. Liu has served as the company's vice president of finance since January 2011. Release. > RRD International has appointed J. Scott Tarrant ...
Lincoln Park Capital Fund invests in more CA biotech
It is the second deal in a few months involving Lincoln Park and a Bay Area biotech company. In April, the fund committed $18.5 million to Hayward, CA, lupus drug developer Anthera Pharmaceuticals Inc. Continue reading the full story by Ron Leuty at ...
Related articles »